Showing results (111-120 of 120) with videos related to
Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 120 results.
CPT: Pharmacometrics & Systems Pharmacology|October 5, 2021
Elevated acute phase proteins affect pharmacokinetics in COVID-19 trials: Lessons from the CounterCOVID - imatinib studyImke H Bartelink, Pierre M Bet, Nicolas Widmer, et al.Trials|December 20, 2019
Right Dose Right Now: bedside data-driven personalized antibiotic dosing in severe sepsis and septic shock - rationale and design of a multicenter randomized controlled superiority trialLuca F Roggeveen, Lucas M Fleuren, Tingjie Guo, et al.Regional Anesthesia and Pain Medicine|January 14, 2022
ED90 of spinal 2-chloroprocaine 1% in ambulatory knee arthroscopy up to 45 min: a randomized biased-coin- up-and-down sequential allocation trialElsbeth J Wesselink, Seppe J Koopman, Rien van der Vegt, et al.The Journal of Climate Change and Health|February 6, 2026
Unused medication: mapping the impact across the Dutch healthcare systemRou Qing Chen, Elisabeth M Smale, Patricia M L A van den Bemt, et al.European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|December 6, 2024
Challenges in the identification and quantification of an unknown impurity in chenodeoxycholic acid drug substanceNatalja Bouwhuis, Yasmin Polak, Anneliene M Schimmel, et al.Critical Care (London, England)|September 5, 2022
Right dose, right now: bedside, real-time, data-driven, and personalised antibiotic dosing in critically ill patients with sepsis or septic shock-a two-centre randomised clinical trialLuca F Roggeveen, Tingjie Guo, Lucas M Fleuren, et al.British Journal of Clinical Pharmacology|October 27, 2017
Predicting CYP3A-mediated midazolam metabolism in critically ill neonates, infants, children and adults with inflammation and organ failureJanneke M Brussee, Nienke J Vet, Elke H J Krekels, et al.Clinical Pharmacology and Therapeutics|June 23, 2025
Model-Informed Precision Dosing of Busulfan for Children and Adults Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: A Critical Evaluation of Current PK Models and Dose RecommendationsRashudy F Mahomedradja, Tim Bognàr, Kaj E van Schie, et al.Thrombosis Research|February 20, 2024
Smaller nadroparin dose reductions required for patients with renal impairment: A multicenter cohort studyRenate C A E van Uden, Tessa C C Jaspers, Karina Meijer, et al.Critical Care (London, England)|June 8, 2023
Efficacy and safety of intravenous imatinib in COVID-19 ARDS: a randomized, double-blind, placebo-controlled clinical trialLeila N Atmowihardjo, Job R Schippers, Erik Duijvelaar, et al.Pageof 12